SCHEMBL4180972

SCHEMBL4180972

CCCN(CCC)CCCN(CCC)CCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
DRD2 P14416 2/20 0.34
DRD3 P35462 2/20 0.34
HTR1A P08908 1/20 0.34
TSHR P16473 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
DRD1 P21728 1/20 0.33
DRD4 P21917 1/20 0.33
DRD5 P21918 1/20 0.33
ADRA1D P25100 1/20 0.33
ADRA1A P35348 1/20 0.33
ADRA1B P35368 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL755906 1.00 LCK (0.36) LCKHRH3CA12CA2CA9
SCHEMBL12994202 0.93 CA12 (0.40) CA12CA9TSHRDNM1CA1
SCHEMBL1815452 0.92 DNM1 (0.40) HRH3CA12CA2CA9DRD2
SCHEMBL759260 0.92 DNM1 (0.40) HRH3CA12CA2CA9DRD2
SCHEMBL14432663 0.90 SIGMAR1 (0.37) HRH3DRD2DRD3HTR1ADRD1
SCHEMBL3480441 0.89 CA12 (0.42) CA12CA9TSHRDNM1CA1
SCHEMBL757613 0.89 DNM1 (0.45) TSHRDNM1
SCHEMBL218572 0.89 CA12 (0.42) CA12CA9TSHRDNM1CA1
SCHEMBL219200 0.89 CA12 (0.42) CA12CA9TSHRDNM1CA1
SCHEMBL757215 0.89 DNM1 (0.45) TSHRDNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279290-A1 COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS MESO SCALE TECHNOLOGIES LLC (US) 2023-09-07 US claimed
EP-2605069-B1 RINSE LIQUID FOR LITHOGRAPHY AND METHOD FOR FORMING PATTERN USING SAME MERCK PATENT GMBH (DE) 2021-09-22 EP claimed
EP-3208659-A1 COMPOSITION FOR RESIST PATTERNING AND METHOD FOR FORMING PATTERN USING SAME AZ Electronic Materials (Luxembourg) S.à.r.l. (LU) 2017-08-23 EP claimed
US-20170219927-A1 COMPOSITION FOR RESIST PATTERNING AND METHOD FOR FORMING PATTERN USING SAME AZ ELECTRIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) 2017-08-03 US claimed
US-9442117-B2 Method for the detection of biological molecules using a two particle complex BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2016-09-13 US claimed
US-20150044669-A1 METHOD FOR THE DETECTION OF BIOLOGICAL MOLECULES USING A TWO PARTICLE COMPLEX BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-02-12 US claimed
EP-1436598-B1 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME MESO SCALE TECHNOLOGIES LLC (US) 2013-11-27 EP claimed
US-20130164694-A1 RINSE SOLUTION FOR LITHOGRAPHY AND PATTERN FORMATION METHOD EMPLOYING THE SAME AZ ELECTRONIC MATERIALS USA CORP. (US) 2013-06-27 US claimed
EP-2605069-A1 RINSE LIQUID FOR LITHOGRAPHY AND METHOD FOR FORMING PATTERN USING SAME AZ Electronic Materials USA Corp. (US) 2013-06-19 EP claimed
US-8188243-B2 Methods and compositions for the detection of biological molecules using a two particle complex BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2012-05-29 US claimed
EP-1436598-A4 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME MESO SCALE TECHNOLOGIES LLC (US) 2007-10-31 EP claimed
US-20070116600-A1 Detection device and methods associated therewith BIOVERIS CORPORATION 2007-05-24 US claimed
WO-2007005626-A1 COMPOSITIONS AND METHODS FOR DETECTING, AMPLIFYING, AND/OR ISOLATING NUCLEIC ACIDS BIOVERIS CORPORATION (US) 2007-01-11 WO claimed
US-20060078912-A1 Methods and compositions for the detection of biological molecules using a two particle complex BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2006-04-13 US claimed
US-6919173-B2 Electrochemiluminescence; kinases; phosphatases MESO SCALE TECHNOLOGIES, LLC. (US) 2005-07-19 US claimed
EP-1436598-A1 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Meso Scale Technologies LLC (US) 2004-07-14 EP claimed
US-20030175803-A1 Electrochemiluminescence; kinases; phosphatases MESO SCALE TECHNOLOGIES, LLC. 2003-09-18 US claimed
WO-2003023380-A1 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME MESO SCALE TECHNOLOGIES, LLC (US) 2003-03-20 WO claimed
EP-0424171-B1 Perfluoro-N,N,N',N'-tetrapropyldiaminopropane and use thereof in vapor phase heating MINNESOTA MINING & MFG (US) 1993-12-29 EP claimed
EP-0424171-A2 Perfluoro-N,N,N',N'-tetrapropyldiaminopropane and use thereof in vapor phase heating MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1991-04-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030175803-A1 Electrochemiluminescence; kinases; phosphatases PRKACA, DUSP3, PPP6C LCK 74/4885HRH3 4597/4885CA12 1083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.